Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	DUF4599	SPATA31D4 SPATA31D3	7.89e-05	12	21	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	7.89e-05	12	21	2	IPR027970
Domain	WW_DOMAIN_2	MAGI2 ARHGAP9	1.49e-03	51	21	2	PS50020
Domain	WW_DOMAIN_1	MAGI2 ARHGAP9	1.49e-03	51	21	2	PS01159
Domain	WW_dom	MAGI2 ARHGAP9	1.54e-03	52	21	2	IPR001202
Pubmed	NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons.	NYAP1 MYO16	8.76e-05	22	22	2	21946561
Pubmed	A genome-wide association study (GWAS) for bronchopulmonary dysplasia.	HIVEP3 MAGI2	2.12e-04	34	22	2	23897914
Cytoband	9q21.32	SPATA31D4 SPATA31D3	3.73e-05	19	22	2	9q21.32
Cytoband	Ensembl 112 genes in cytogenetic band chr9q21	SPATA31D4 SPATA31D3	4.08e-03	199	22	2	chr9q21
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP9 GAB1	9.28e-03	206	13	2	682
GeneFamily	RNA binding motif containing	RBM33 DAZL	9.89e-03	213	13	2	725
Disease	chronotype measurement	PER2 MAGI2 ARHGAP9 MYO16 BARHL2	1.46e-04	882	18	5	EFO_0008328
Disease	visceral adipose tissue measurement	HIVEP3 MAGI2 HELZ LGALS12	1.78e-04	481	18	4	EFO_0004765
Disease	bronchopulmonary dysplasia	HIVEP3 MAGI2	3.43e-04	45	18	2	MONDO_0019091
Disease	Abnormality of refraction	HIVEP3 MAGI2 CCAR2 BARHL2	6.36e-04	673	18	4	HP_0000539
Disease	refractive error	NYAP1 HIVEP3 BARHL2	9.64e-04	326	18	3	MONDO_0004892
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	HIVEP3 MAGI2 NFU1	1.32e-03	364	18	3	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	opioid use disorder	MAGI2 BARHL2	1.71e-03	101	18	2	EFO_0010702
Disease	cup-to-disc ratio measurement	HELZ ARHGAP9 MYO16	2.13e-03	430	18	3	EFO_0006939
Disease	cannabis dependence	MAGI2 BARHL2	3.03e-03	135	18	2	EFO_0007191
Disease	body fat percentage	HIVEP3 MAGI2 NFU1	3.05e-03	488	18	3	EFO_0007800
Disease	nasopharyngeal neoplasm	HELZ GAB1	3.77e-03	151	18	2	EFO_0004252
Disease	circadian rhythm	PER2 BARHL2	4.38e-03	163	18	2	EFO_0004354
Disease	Hypermetropia, Myopia	HIVEP3 BARHL2	5.84e-03	189	18	2	HP_0000540, HP_0000545
Disease	refractive error, age at onset, Myopia	HIVEP3 B4GALNT2	6.08e-03	193	18	2	EFO_0004847, HP_0000545, MONDO_0004892
Disease	monocyte count	NYAP1 HIVEP3 ARHGAP9 MYO16	7.38e-03	1320	18	4	EFO_0005091
Disease	alcohol use disorder measurement	MAGI2 BARHL2	7.42e-03	214	18	2	EFO_0009458
Disease	biological sex	DAZL BARHL2	8.53e-03	230	18	2	PATO_0000047
Disease	monocyte percentage of leukocytes	B4GALNT2 ARHGAP9 MYO16	9.36e-03	731	18	3	EFO_0007989
Disease	risk-taking behaviour	HIVEP3 MAGI2 BARHL2	1.06e-02	764	18	3	EFO_0008579
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	MAGI2 HELZ BARHL2	1.20e-02	801	18	3	EFO_0003888, EFO_0007052, MONDO_0002491

Protein segments in the cluster

Peptide	Gene	Start	Entry
PQLIFQPHRIPPLFP	CCAR2	146	Q8N163
QPHRIPPLFPQKPLS	CCAR2	151	Q8N163
QLPPQRPQPCPHYPL	CCDC185	126	Q8N715
FFQLPAPHPPTVLRP	LINC01590	11	Q5TEZ4
LPRPLPLLVQPNLPF	B4GALNT2	181	Q8NHY0
FQPQPLQPLLPVQHP	RBM33	336	Q96EV2
PAIPQNLPFPPALHR	MAGI2	711	Q86UL8
PLHQFVQRPLFPLPA	NFU1	36	Q9UMS0
PFPNLLPHRPPLLVF	MYO16	1481	Q9Y6X6
ATLPPPYQLINVPPH	GAB1	156	Q13480
VQFPVPNLEVLPRPP	KATNB1	426	Q9BVA0
QHQFAVQPPPFPAPL	PER2	886	O15055
PIPDSFILQPPVFHP	LGALS12	31	Q96DT0
LPRPPFPIPQQHTLL	HELZ	1366	P42694
PAPHPQLQRPLVPRV	BARHL2	346	Q9NY43
PKHLPPLPRTYPQNL	FAM166B	221	A8MTA8
PRPLVFNHPPPPQFQ	DAZL	126	Q92904
CEIPPPFPNLLQHRP	NYAP1	321	Q6ZVC0
PFPNLLQHRPPLLAF	NYAP1	326	Q6ZVC0
PPGPLPRYRPQQHLL	PRORY	106	Q9H606
PIDHSPPQQLPFPLL	SPATA31D4	231	Q6ZUB0
PIDHSPPQQLPFPLL	SPATA31D3	231	P0C874
FQAPPLPLQPTVLHP	HIVEP3	1186	Q5T1R4
HPANIPFRQPPSFLP	HIVEP3	1211	Q5T1R4
LPQPLVPPLLLPHFR	ARHGAP9	641	Q9BRR9
LQHLPPSTLLPRPPF	ZNF843	206	Q8N446